Physiologically Based Pharmacokinetic Modeling of Persistent OrganicPollutants for Lifetime Exposure Assessment: A New Tool in Breast CancerEpidemiologic Studies
- 1 July 2008
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 116 (7) , 886-892
- https://doi.org/10.1289/ehp.10917
Abstract
Despite experimental evidence, most epidemiologic studies to date have not supported an association between exposure to persistent organic pollutants (POP) and breast cancer incidence in humans. This may be attributable to difficulties in estimating blood/tissue POP concentration at critical time periods of carcinogenesis. In this work we aimed to develop a tool to estimate lifetime POP blood/tissue exposure and levels during any hypothesized time window of susceptibility in breast cancer development. We developed a physiologically based pharmacokinetic (PBPK) model that can account for any given physiologic lifetime history. Using data on pregnancies, height, weight, and age, the model estimates the values of physiologic parameters (e.g., organ volume, composition, and blood flow) throughout a woman's entire life. We assessed the lifetime toxicokinetic profile (LTP) for various exposure scenarios and physiologic factors (i.e., breast-feeding, growth, pregnancy, lactation, and weight changes). Simulations for three POPs [hexachlorobenzene, polychlorinated biphenyl (PCB)-153, PCB-180] using different lifetime physiologic profiles showed that the same blood concentration at 55 years of age can be reached despite totally different LTP. Aside from exposure levels, lactation periods and weight profile history were shown to be the factors that had the greatest impact on the LTP. This new lifetime PBPK model, which showed the limitations of using a single sample value obtained around the time of diagnosis for lifetime exposure assessment, will enable researchers conducting environmental epidemiology studies to reduce uncertainty linked to past POP exposure estimation and to consider exposure during time windows that are hypothesized to be mechanistically critical in carcinogenesis.Keywords
This publication has 55 references indexed in Scilit:
- Pharmacokinetic Variability and Modern Epidemiology—The Example of Dichlorodiphenyltrichloroethane, Body Mass Index, and Birth CohortCancer Epidemiology, Biomarkers & Prevention, 2007
- DDT and Breast Cancer in Young Women: New Data on the Significance of Age at ExposureEnvironmental Health Perspectives, 2007
- Development of Physiologically Based Toxicokinetic Models for Improving the Human Indoor Exposure Assessment to Water Contaminants: Trichloroethylene and TrihalomethanesJournal of Toxicology and Environmental Health, Part A, 2006
- 4-Hydroxy-PCB106 acts as a direct thyroid hormone receptor agonist in rat GH3 cellsMolecular and Cellular Endocrinology, 2006
- Toxicity of Hydroxylated and Quinoid PCB Metabolites: Inhibition of Gap Junctional Intercellular Communication and Activation of Aryl Hydrocarbon and Estrogen Receptors in Hepatic and Mammary CellsChemical Research in Toxicology, 2004
- Excretion of hexachlorobenzene and metabolites in feces in a highly exposed human population.Environmental Health Perspectives, 2000
- Using Structural Information to Create Physiologically Based Pharmacokinetic Models for all Polychlorinated BiphenylsToxicology and Applied Pharmacology, 1998
- A Generic Toxicokinetic Model for Persistent Lipophilic Compounds in Humans: An Application to TCDDFundamental and Applied Toxicology, 1996
- Using mortality data to estimate radiation effects on breast cancer incidence.Environmental Health Perspectives, 1990
- Distribution and excretion of 2,2′,4,4′,5,5′-hexabromobiphenyl in rats and man: Pharmacokinetic model predictionsToxicology and Applied Pharmacology, 1980